Research and experimental development on natural sciences and engineering
CEROLU AS
Revenue 2025
NOK 306,000
Operating profit
NOK 267,000
Equity
NOK −200,000
Incorporated
2012
Share capital
NOK 30,000
Roles
Regnskapsfører
Styrets lederHåvard Hildeng Hauge
VaramedlemTina Kihlstrand Hauge
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| HÅVARD HILDENG HAUGE | 100.0% | 30000.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| BIOMOLEX AS | Active | 21.5% | 178431.000000 |
| ARCTIC PHARMA AS | Active | 3.0% | 3279.000000 |
| VITAE EVIDENCE AS | Active | 1.0% | 767.000000 |
| COREMINE VITAE AS | Active | 0.1% | 1391.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.